Neumora Therapeutics, Inc. (NMRA) — Long-term Investment Intensity
Neumora Therapeutics, Inc. (NMRA) has a Long-term Investment Intensity of 0.1% as of March 2024. Long-term investments of $302.00K represent 0.1% of total assets of $450.21 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Explore NMRA cash flow metrics to assess how effectively this company generates cash.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Neumora Therapeutics, Inc. Long-term Investment Intensity (2022–2023)
This chart shows how Neumora Therapeutics, Inc.'s Long-term Investment Intensity has evolved across 2 annual periods from 2022 to 2023. As of March 2024, the intensity stands at 0.1%, reflecting long-term investments of $302.00K against total assets of $450.21 Million USD. Explore Neumora Therapeutics, Inc. (NMRA) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Neumora Therapeutics, Inc. (2022–2023)
The table below presents the year-by-year Long-term Investment Intensity for Neumora Therapeutics, Inc. from 2022 to 2023, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see NMRA market cap.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2023 | 2.0% | $9.85 Million | $496.19 Million | ▼ -3.5 pp |
| 2022 | 5.5% | $23.51 Million | $426.23 Million | — |